Finding Solutions Together
It takes collaboration to make science more transformative
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. The recent EUPROMS* study discovered 50% of men report sexual function to be a moderate or big problem at 6 years, whilst only 34% of them had tried any treatments. It highlighted a significant impact to urinary incontinence too, and at a far greater rate than previous studies have concluded.
Why do some men seem to have free access to treatments for ED and incontinence following treatment for prostate cancer? Why do some patients find their way to a specialist after years of suffering, surprised to learn that there are well defined treatments available for both conditions beyond first line medication? This inequitable access, and the delays it inevitably leads to in treatment becomes especially poignant when considering that a study by Redmond et al** concluded that ‘Patients with PPI (post-prostatectomy incontinence) may be at higher risk of developing new comorbidities while awaiting anti-incontinence surgery which may be related to the duration of incontinence’
Through our partnership with Guy’s and St Thomas NHS Trust and Nexus Medical Technologies, we are working towards an integrated and considered care pathway for patients following treatment for prostate cancer. This ‘Post Radical-Prostatectomy Survivorship Care Pathway’ will consider the functional and sexual needs of the man as they progress on their journey back to health, with the ultimate goal to provide a blueprint for healthcare providers across the NHS to care for their prostate cancer survivors holistically and efficiently.
Please join us at 18:30 on the 22nd September for our webinar on this program, delivered by Majed Shabbir Consultant Urologist, Guys Hospital, London. Mr Shabbir will describe the background behind the project and what drove them to explore the pathway, and elaborate on how the partnership with Nexus supports the engagement of the patient with their own survivorship, and how it allows seamless and integrated communication between them and their healthcare professionals.
* Deschamps A. The real effect of prostate cancer treatment: EUPROMS study first patient driven quality of life study ever. 2020 European Association of Urology Virtual Congress. July 17-26, 2020 - Summary: https://www.urotoday.com/conference-highlights/eau-2020/prostate-cancer/123235-eau-2020-the-real-effect-of-prostate-cancer-treatment-euproms-first-ever-prostate-patient-driven-quality-of-life-study.html
** Redmond E. OBESITY, WEIGHT GAIN AND NEW COMORBIDITIES IN PATIENTS WITH URINARY INCONTINENCE FOLLOWING PROSTATE CANCER SURGERY, THE JOURNAL OF UROLOGY Vol. 203, No. 4S - https://www.auajournals.org/doi/pdf/10.1097/JU.0000000000000908.02